Modeling leukemia with human induced pluripotent stem cells

6Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

The reprogramming of human somatic cells into induced pluripotent stem cells (iPSCs) a little over a decade ago raised exciting prospects to transform the study and potentially also the therapy of human diseases. iPSC models have now been created for a multitude of hematologic diseases, including malignancies. Here we discuss practical aspects of iPSC modeling of malignant diseases, review recent studies, and discuss the new opportunities that iPSC models offer, as well as their current limitations and prospects for future development.

Cite

CITATION STYLE

APA

Papapetrou, E. P. (2019). Modeling leukemia with human induced pluripotent stem cells. Cold Spring Harbor Perspectives in Medicine, 9(12). https://doi.org/10.1101/cshperspect.a034868

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free